New narcolepsy pill mimics Brain's Wake-Up signal in major trial
NCT ID NCT07598708
First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 4 times
Summary
This study tests an experimental drug called cleminorexton in 222 adults with narcolepsy type 1 or 2. The drug mimics a natural brain protein that helps keep people awake. The goal is to see if it safely reduces daytime sleepiness and improves daily functioning. Participants must stop their current narcolepsy medications during the trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cincinnati, Ohio
RECRUITINGCincinnati, Ohio, 45245, United States
-
Columbia, South Carolina
RECRUITINGColumbia, South Carolina, 29201, United States
-
Denver, North Carolina
RECRUITINGDenver, North Carolina, 28037, United States
-
Huntersville, North Carolina
RECRUITINGHuntersville, North Carolina, 28078, United States
-
Miami Lakes, Florida
RECRUITINGMiami Lakes, Florida, 33014, United States
-
Miami, Florida
RECRUITINGMiami, Florida, 33176, United States
-
Sugar Land, Texas
RECRUITINGSugar Land, Texas, 77478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New test could sharpen diagnosis of narcolepsy and related sleep disorders
- New pill aims to tame Narcolepsy's sleep attacks and sudden muscle weakness
- Dream control: a new behavioral approach to tame narcolepsy nightmares
- New drug TAK-360 tested for Long-Term safety in sleep disorders
- New hope for narcolepsy: TAK-360 trial seeks to tame sudden muscle weakness
- New dosing options for xywav could help fight daytime sleepiness